Identifying the best treatment among common nonsurgical neck pain treatments: A decision analysis

Spine

Volumn 33, Issue 4 SUPPL., 2008, Pages

  Van Der Velde, Gabrielle ^a,b,c,d   Hogg Johnson, Sheilah ^a,b   Bayoumi, Ahmed M ^b,e,f,g   Cassidy, J David ^b,c,d   Côté, Pierre ^a,b,c,d   Boyle, Eleanor ^c,d   Llewellyn Thomas, Hilary ^h   Chan, Stella ^a   Subrata, Peter ^a   Hoving, Jan Lucas ⁱ   Hurwitz, Eric ^j   Bombardier, Claire ^a,b,k   Krahn, Murray ^b,k  

^a INSTITUTE FOR WORK AND HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h DARTMOUTH MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j UNIVERSITY OF HAWAII   (United States)

^k UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

Decision analysis; Effectiveness; Exercise; Manual therapy; Neck pain; Nonsteroidal anti inflammatory drug; Quality of life; Treatment risk

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXERCISE; HUMAN; LIFE EXPECTANCY; MANIPULATIVE MEDICINE; NECK PAIN; PHYSICAL MOBILITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; EXERCISE THERAPY; FEMALE; HUMANS; IATROGENIC DISEASE; LIFE EXPECTANCY; MALE; MANIPULATION, SPINAL; MIDDLE AGED; MODELS, STATISTICAL; NECK PAIN; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY;

EID: 38549144911     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31816454f8     Document Type: Article

References (96)

1. Côté P, Cassidy JD, Carroll L. The treatment of neck and low back pain: who seeks care? Who goes where? Med Care 2001;39:956-67.
2. Hurwitz EL, Morgenstern H. The effect of comorbidity on care seeking for back problems in the United States. Ann Epidemiol 1999;9:262-70.
3. Lim KL, Jacobs P, Klarenbach S. A population-based analysis of healthcare utilization of persons with back disorders: results from the Canadian Community Health Survey 2000-2001. Spine 2006;31:212-18.
4. Hurwitz EL, Coulter ID, Adams AH, et al. Use of chiropractic services from 1985 through 1991 in the United States and Canada. Am J Public Health 1998;88:771-6.
5. Vos C, Verhagen A, Passchier J, et al. Management of acute neck pain in general practice: a prospective study. Br J Gen Prac 2007;57:23-8.
6. Riddle DL, Schappert SM. Volume and characteristics of inpatient and ambulatory medical care for neck pain in the United States: data from three national surveys. Spine 2007;32:132-41.
7. Christensen MG, Kerkoff D, Kollasch MW. Job Analysis of Chiropractic, 2000: A Project Report, Survey Analysis, and Summary of Chiropractic Practice Within the United States. Greeley: National Board of Chiropractic Examiners; 2000.
8. Binder AI. Cervical spondylosis and neck pain. BMJ 2007;334:527-31.
9. Hurwitz EL, Carragee EJ, van der Velde G, et al. Treatment of neck pain: noninvasive interventions: Results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008;33(Suppl):S123-S152.
10. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials. BMJ 2006;332:1302-8.
11. Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal antiinflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000;160:2093-9.
12. Rothwell DM, Bondy SJ, Williams JI. Chiropractic manipulation and stroke: a population-based case-control study. Stroke 2001;32:1054-60.
13. Philips Z, Bojke L, Sculpher M, et al. Good practice guidelines for decisionanalytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006;24:355-71.
14. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford University Press; 2005.
15. Von Korff M, Ormel J, Keefe FJ, et al. Grading the severity of chronic pain. Pain 1992;50:133-49.
16. Von Korff M, Dworkin SF, Le Resche L. Graded chronic pain status: an epidemiologic evaluation. Pain 1990;40:279-91.
17. Von Korff M, Dworkin SF, Le Resche L, et al. An epidemiologic comparison of pain complaints. Pain 1988;32:173-83.
18. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
19. McGettigan P, Herbert RD. Cardiovascular risk and inhibition of cyclooxygenase. JAMA 2006;296.
20. Moore RA, Derry S, Makinson GT, et al. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther 2005;7:R644-R665.
21. Ofman JJ, MacLean CH, Straus WL, et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol 2002;29:804-12.
22. Salpeter SR, Gregor P, Ormiston TM, et al. Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med 2006;119:552-9.
23. Tosteson ANA. Preference-based health outcome measures in low back pain. Spine 2000;25:3161-6.
24. Coulter ID, Hurwitz EL, Adams AH, et al. Patients using chiropractors in North America: who are they, and why are they in chiropractic care? Spine 2002;27:291-6.
25. Hurwitz EL, Morgenstern H, Harber P, et al. A randomized trial of chiropractic manipulation and mobilization for patients with neck pain: clinical outcomes from the UCLA neck-pain study. Am J Pub Health 2002;92:1634-41.
26. Hurwitz EL, Chiang LM. A comparative analysis of chiropractic and general practitioner patients in North America: findings from the joint Canada/United States Survey of Health, 2002-03. BMC Health Serv Res 2006;6:49.
27. Korthalsde BI, Hoving JL, van Tulder MW, et al. Cost effectiveness of physiotherapy, manual therapy, and general practitioner care for neck pain: economic evaluation alongside a randomized controlled trial. BMJ 2003;326:911.
28. Hogg-Johnson S, van der Velde G, Carroll LJ, et al. The burden and determinants of neck pain in the general population: Results of the Bone and Joint decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008;33(Suppl):S39-S51.
29. Côté P, Cassidy JD, Carroll LJ, et al. The annual incidence and course of neck pain in the general population: a population-based cohort study. Pain 2004;112:267-73.
30. Boyle E, Côté P, Grier A, et al. Examining vertebrobasilar artery stroke in two canadian provinces. Spine 2008;33(Suppl):S170-S175.
31. Vrbova L, Crighton EJ, Mamdani M, et al. Temporal analysis of acute myocardial infarction in Ontario, Canada. Can J Cardiol 2005;21:841-5.
32. Rosamond WD, Folsom AR, Chambless LE, et al. Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996. Int J Epidemiol 2001;30:S17-S22.
33. McGovern PG, Jacobs DR Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 2001;104:19-24.
34. Bata IR, Gregor RD, Eastwood BJ, et al. Trends in the incidence of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project. Can J Cardiol 2000;16:589-95.
35. Pilote L, Lavoie F, Ho V, et al. Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995. CMAJ 2000;163:31-6.
36. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
37. Goldberg RJ, Cui J, Olendzki B, et al. Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction. Am Heart J 2006;151:1297-304.
38. Cox JL, Bata IR, Gregor RD, et al. Trends in event rate and case fatality of patients hospitalized with myocardial infarction between 1984 and 2001. Can J Physiol Pharmacol 2006;84:121-7.
39. Spencer FA, Meyer TE, Gore JM, et al. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation 2002;105:2605-10.
40. Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001;110:165-74.
41. Goldberg RJ, Yarzebski J, Lessard D, et al. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999;33:1533-9.
42. Witt BJ, Ballman KV, Brown RD Jr, et al. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med 2006;119:354e1-e9.
43. Hellermann JP, Goraya TY, Jacobsen SJ, et al. Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 2003;157:1101-7.
44. Spencer FA, Meyer TE, Goldberg RJ, et al. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999;34:1378-87.
45. Ali AS, Rybicki BA, Alam M, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J 1999;138:1133-9.
46. Hellermann JP, Jacobsen SJ, Gersh BJ, et al. Heart failure after myocardial infarction: a review. Am J Med 2002;113:324-30.
47. Jong P, Vowinckel E, Liu PP, et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002;162:1689-94.
48. Johansen HL, Wielgosz AT, Nguyen K, et al. Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada. Can J Cardiol 2006;22:65-71.
49. Kleindorfer D, Broderick J, Khoury J, et al. The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke 2006;37:2473-8.
50. Field TS, Green TL, Roy K, et al. Trends in hospital admission for stroke in Calgary. Can J Neurol Sci 2004;31:387-93.
51. Tu JV, Gong Y. Trends in treatment and outcomes for acute stroke patients in Ontario, 1992-1998. Arch Intern Med 2003;163:293-7.
52. Kapral MK, Wang H, Mamdani M, et al. Effect of socioeconomic status on treatment and mortality after stroke. Stroke 2002;33:268-73.
53. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006;296:2939-46.
54. Mayo NE, Hendlisz J, Goldberg MS, et al. Destinations of stroke patients discharged from the Montreal area acute-care hospitals. Stroke 1989;20:351-6.
55. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988;1497-500.
56. Mellemkjaer L, Blot WJ, Sorensen HT, et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002;53:173-81.
57. Garcia Rodriguez LA, Walker AM, Perez GS. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992;3:337-42.
58. Cassidy JD, Boyle E, Côté P, et al. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case control and case-crossover study. Spine 2008;33(Suppl):S176-S183.
59. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006;101:945-53.
60. Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005;100:1685-93.
61. Di Fiore F, Lecleire S, Merle V, et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol 2005;17:641-7.
62. Garcia-Rodriguez LA, Ruigomez A, Hasselgren G, et al. Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents. Epidemiology 1998;9:452-6.
63. Rockall TA. Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage. Steering Group for the National Audit of Acute Upper Gastrointestinal Haemorrhage. J R Soc Med 1998;91:518-23.
64. Vreeburg EM, Snel P, de Bruijne JW, et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997;92:236-43.
65. Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995;311:222-6.
66. Ramsoekh D, van Leerdam ME, Rauws EA, et al. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol 2005;3:859-64.
67. Rockall TA, Logan RF, Devlin HB, et al. Influencing the practice and outcome in acute upper gastrointestinal haemorrhage. Steering Committee of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Gut 1997;41:606-11.
68. Sandel MH, Kolkman JJ, Kuipers EJ, et al. Nonvariceal upper gastrointestinal bleeding: differences in outcome for patients admitted to internal medicine and gastroenterological services. Am J Gastroenterol 2000;95:2357-62.
69. Statistics Canada. 2000-2002 Life Tables, Canada, Provinces and Territories, Ottawa, 2006. Statistics Canada Catalogue No. 84-537-XIE.
70. Peeters A, Mamun AA, Willekens F, et al. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 2002;23:458-66.
71. Hoving JLP, de Vet HCWP, Koes BWP, et al. Manual therapy, physical therapy, or continued care by the general practitioner for patients with neck pain: long-term results from a pragmatic randomized clinical trial. Clin J Pain 2006;22:370-7.
72. Hoving JL. Manual therapy, physical therapy, or continued care by a general practitioner for patients with neck pain. A randomized, controlled trial. Ann Intern Med 2002;136:713-22.
73. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute Inc.; 1995.
74. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8.
75. Nadarajah A, Abrahan L, Lau FL, et al. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Singapore Med J 2006;47:534-42.
76. Singh G, Fort JG, Goldstein JL, et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 2006;119:255-66.
77. Jordan A, Bendix T, Nielsen H, et al. Intensive training, physiotherapy, or manipulation for patients with chronic neck pain. A prospective, singleblinded, randomized clinical trial. Spine 1998;23:311-18.
78. Koes BW, Bouter LM, van MH, et al. The effectiveness of manual therapy, physiotherapy, and treatment by the general practitioner for nonspecific back and neck complaints. A randomized clinical trial. Spine 1992;17:28-35.
79. Koes BW, Bouter LM, van MH, et al. Randomised clinical trial of manipulative therapy and physiotherapy for persistent back and neck complaints: results of one year follow up. BMJ 1992;304:601-5.
80. Froberg DG, Kane RL. Methodology for measuring health-state preferences. I. Measurement strategies. J Clin Epidemiol 1989;42:345-54.
81. World Health Organization. International Classification of Functioning, Disability and Health. World Health Organization; 2001.
82. Mach L, Dumais J, Robinson A. A Study of the Properties of a Bootstrap Variance Estimator Under Sampling Without Replacement. Arlington, VA: Federal Committee on Statistical Methodology (FCSM) Research Conference; 2005.
83. Kongsted A, Qerama E, Kasch H, et al. Neck collar, "act-as- usual" or active mobilization for whiplash injury? A randomized parallel-group trial. Spine 2007;32:618-26.
84. Horneij E, Hemborg B, Jensen I, et al. No significant differences between intervention programmes on neck, shoulder and low back pain: a prospective randomized study among home-care personnel. J Rehabil Med 2001;33:170-6.
85. Yamamoto M, Sugano T, Kashiwazaki S, et al. Double-blind comparison of piroxicam and indomethacin in the treatment of cervicobrachial syndrome and periarthritis scapulohumeralis (stiff shoulder). Eur J Rheumatol Inflamm 1983;6:266-73.
86. Zylbergold RS, Piper MC. Cervical spine disorders. A comparison of three types of traction. Spine 1985;10:867-71.
87. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making 1998;18:95-109.
88. Hill J, Lewis M, Papageorgiou AC, et al. Predicting persistent neck pain: a 1-year follow-up of a population cohort. Spine 2004;29:1648-54.
89. Carroll LJ, Hogg-Johnson S, van der Velde G, et al. Course and prognostic factors for neck pain in the general population: Results of the Bone and Joint decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008;33(Suppl):S75-S82.
90. Naimark D, Naglie G, Detsky AS. The meaning of life expectancy: what is a clinically significant gain? J Gen Intern Med 1994;9:702-7.
91. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions-standardizing data on outcomes. N Engl J Med 1998;339:380-6.
92. Zhang J, Ding EL, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 2006;296:1619-32.
93. Swan JS, Lawrence WF, Roy J. Process utility in breast biopsy. Med Decis Making 2006;26:347-59.
94. Swan JS, Sainfort F, Lawrence WF, et al. Process utility for imaging in cerebrovascular disease. Acad Radiol 2003;10:266-74.
95. Brouwer WB, van Exel NJ, van den BB, et al. Process utility from providing informal care: the benefit of caring. Health Policy 2005;74:85-99.
96. Donaldson C, Shackley P. Does "process utility" exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med 1997;44:699-707.